HRT Financial’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,211
| Closed | -$803K | – | 2241 |
|
|
2025
Q1 | $803K | Buy |
+43,211
| New | +$803K | 0.01% | 1056 |
|
|
2024
Q4 | – | Sell |
-8,210
| Closed | -$275K | – | 2173 |
|
|
2024
Q3 | $275K | Buy |
+8,210
| New | +$275K | ﹤0.01% | 1689 |
|
|
2024
Q1 | – | Sell |
-75,633
| Closed | -$1.62M | – | 2139 |
|
|
2023
Q4 | $1.62M | Buy |
+75,633
| New | +$1.62M | 0.01% | 702 |
|
|
2023
Q1 | – | Sell |
-13,013
| Closed | -$403K | – | 2267 |
|
|
2022
Q4 | $403K | Buy |
+13,013
| New | +$403K | 0.01% | 1440 |
|
|
2022
Q3 | – | Sell |
-45,932
| Closed | -$932K | – | 2561 |
|
|
2022
Q2 | $932K | Buy |
+45,932
| New | +$932K | 0.01% | 989 |
|
|
2022
Q1 | – | Sell |
-6,643
| Closed | -$230K | – | 2768 |
|
|
2021
Q4 | $230K | Sell |
6,643
-25,082
| -79% | -$868K | ﹤0.01% | 2178 |
|
|
2021
Q3 | $860K | Sell |
31,725
-54,990
| -63% | -$1.49M | 0.01% | 1311 |
|
|
2021
Q2 | $2.25M | Buy |
+86,715
| New | +$2.25M | 0.02% | 543 |
|
|
2020
Q4 | – | Sell |
-22,745
| Closed | -$335K | – | 1740 |
|
|
2020
Q3 | $335K | Buy |
22,745
+8,697
| +62% | +$128K | 0.01% | 1004 |
|
|
2020
Q2 | $313K | Buy |
+14,048
| New | +$313K | 0.01% | 863 |
|